DA Allows Marketing of First Rapid Ebola Test

Share this post

The FDA has allowed marketing of the first rapid diagnostic test (RDT) to identify Ebola virus antigens, or proteins, in certain body fluids from living and deceased individuals.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply